HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$4.52
Day range
$4.48 - $4.60
Year range
$3.89 - $7.28
Market cap
196.29M USD
Avg Volume
250.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.22M | 553.66% |
Operating expense | 25.89M | 128.84% |
Net income | -15.15M | -363.53% |
Net profit margin | -114.65 | -140.32% |
Earnings per share | -0.40 | -53.85% |
EBITDA | -13.88M | -54.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 67.74M | -18.24% |
Total assets | 172.33M | 49.41% |
Total liabilities | 110.46M | 174.65% |
Total equity | 61.86M | — |
Shares outstanding | 41.85M | — |
Price to book | 3.03 | — |
Return on assets | -23.56% | — |
Return on capital | -33.66% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.15M | -363.53% |
Cash from operations | -16.16M | -262.12% |
Cash from investing | 10.58M | 16,901.59% |
Cash from financing | 5.00M | 2,047.08% |
Net change in cash | -220.00K | 95.21% |
Free cash flow | 42.62M | 2,461.33% |
About
Founded
2006
Website
Employees
67